化痰通络方加减联合叶酸、维生素B12治疗高同型半胱氨酸血症型急性脑梗死的效果观察
[摘要]目的 觀察化痰通络方加减联合叶酸、维生素B12 治疗高同型半胱氨酸血症(HHcy)型急性脑梗死(ACI)的效果,为ACI二级预防提供更多的临床证据。方法 选取2015年2月~2016年3月我院收治的86例HHcy型ACI患者随机分为对照组40例和观察组46例。对照组予以叶酸、维生素B12及降压、降糖、调脂及抗血小板等基础治疗,观察组在对照组基础上加用化痰通络方加减。分别于治疗前及治疗2周后检测血清Hcy水平、NIHSS评分。结果 观察组的总有效率为89.13%,与对照组的70.00%比较,差异有统计学意义(P<0.05);与治疗前比较,两组治疗2周后的血清Hcy水平、NIHSS评分均降低,差异有统计学意义:对照组(P<0.05,P<0.01);与对照组治疗后比较,观察组血清Hcy明显降低,NIHSS评分也显著降低(P<0.05)。结论 化痰通络方加减联合叶酸片及维生素B12能有效降低HHcy型ACI患者的血浆Hcy水平,从而改善ACI患者的预后及提高其生活质量。
[关键词]化痰通络方;叶酸;维生素B12;高同型半胱氨酸血症型急性脑梗死
[中图分类号] R743.9 [文献标识码] A [文章编号] 1674-4721(2017)09(b)-0138-03
Effect observation of modified Huatan Tongluo Prescription combined with Folic Acid and Vitamin B12 in the treatment of hyperhomocysteinemia-type acute cerebral infarction
DONG Li SUN Hui-hong GE Jian-wen
Department of Encephalopathy,Tianshui Traditional Chinese Medicine Hospital,Gansu Province,Tianshui 741000,China
[Abstract]Objective To observe the effect of modified Huatan Tongluo Prescription combined with Folic Acid and Vitamin B12 in the treatment of hyperhomocysteinemia (HHcy) -type acute cerebral infarction (ACI),and to provide more clinical evidence for secondary prevention of ACI.Methods 86 patients with HHcy-type ACI admitted into our hospital from February 2015 to March 2016 were selected and randomly divided into control group (n=40) and observation group (n=46).In the control group,basic treatments including Folic Acid,Vitamin B12,decompression,blood glucose reducing,lipid regulation...
== 试读已结束,如需继续阅读敬请充值会员 ==
|
本站文章均为原创投稿,仅供下载参考,付费用户可查看完整且有格式内容!
(费用标准:38元/2月,98元/2年,微信支付秒开通!) |
升级为会员即可查阅全文 。如需要查阅全文,请 免费注册 或 登录会员 |